The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy

Author: Carides George W.  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.24, Iss.6, 2006-01, pp. : 549-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract